Skip to main content
EMVISION MEDICAL DEVICES LTD logo

EMVISION MEDICAL DEVICES LTD — Investor Relations & Filings

Ticker · EMV ISIN · AU0000028375 ASX Manufacturing
Open in API
Filings indexed 304 across all filing types
Latest filing 2019-11-04 Capital/Financing Update
Country AU Australia
Listing ASX EMV

About EMVISION MEDICAL DEVICES LTD

https://emvision.com.au/

EMVision Medical Devices Ltd is a medical technology company focused on the development and commercialization of portable medical imaging devices. The company specializes in electromagnetic microwave imaging technology designed for the rapid diagnosis and monitoring of stroke and traumatic brain injury. Its primary product is a portable brain scanner intended for use at the point of care, including intensive care units, emergency departments, and ambulances. By utilizing non-ionizing radiation, the technology provides a safe, cost-effective, and mobile alternative to traditional neuroimaging modalities like CT and MRI. The device aims to facilitate earlier clinical intervention by enabling bedside assessment, potentially improving patient outcomes through faster detection of ischemic and hemorrhagic strokes.

Recent filings

Filing Released Lang Actions
EMVision Completes $4.5M Placement 2 pages 146.9KB
Capital/Financing Update Classification · 100% confidence The document is a press release announcing the completion of a $4.5 million placement by EMVision Medical Devices Limited. It details the amount raised, the number of shares issued, the issue price, and the use of proceeds. There is no financial statement or detailed financial report included. The document is focused on a capital raising event and the issuance of new shares under existing placement capacity. It is not an annual or interim report, audit report, earnings release, or any other detailed financial or governance report. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is 5374 characters, which is sufficient to contain substantive information about the financing event rather than just an announcement of a report publication or a brief notice.
2019-11-04 English
Trading Halt 2 pages 238.6KB
Capital/Financing Update Classification · 95% confidence The document is a market announcement from EMVision Medical Devices Ltd regarding a trading halt requested pending an announcement about a proposed capital raising. It references ASX Listing Rule 17.1 and states the halt is until the announcement or a specific date. The document does not contain financial statements, detailed financial data, or the actual capital raising details, but is an announcement about the trading halt itself. This fits the category of Capital/Financing Update (CAP) as it relates to financing activities and capital raising announcements, not a full report or regulatory filing. The document length is short and it is not a report publication announcement or certification. Therefore, the best classification is CAP with high confidence.
2019-10-31 English
EMVision Completes First Clinical Unit Targeting Stroke 3 pages 4.8MB
Regulatory Filings Classification · 85% confidence The document is a company announcement dated 31/10/19 from EMVision Medical Devices Ltd. It discusses the completion of the company's first clinical unit for stroke diagnosis, details about the device, upcoming clinical trials, and background information about the company and its leadership. There are no financial statements, regulatory filings, or detailed financial performance data. The content is primarily a business update about product development and clinical trial progress. It does not fit categories like Annual Report, Interim Report, Earnings Release, or any financial report. It is also not a regulatory filing or certification. The document is a corporate announcement about a milestone in product development and clinical trial readiness, which aligns best with a Capital/Financing Update (CAP) as it relates to company progress and potential future revenue generation from the new device. However, since it is more of a product development update without explicit financing or capital structure changes, the best fit is Regulatory Filings (RNS) as a general announcement category for miscellaneous company updates that do not fit other specific categories.
2019-10-30 English
Appendix 4C - quarterly 8 pages 310.9KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'APPENDIX 4C – 30 SEPTEMBER 2019 QUARTERLY CASHFLOW REPORT' and contains detailed financial data including cash flow statements for the quarter ended 30 September 2019. It references compliance with ASX Listing Rule 4.7B, which mandates quarterly cash flow reporting for listed entities in Australia. The document includes actual financial figures, cash flow from operating, investing, and financing activities, and commentary on cash reserves and grant funding. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is a financial report rather than a brief announcement or certification. The quarterly nature and detailed financial statements align with the definition of an Interim / Quarterly Report (IR). Q1 2020
2019-10-30 English
Notice of Annual General Meeting/Proxy Form 20 pages 624.6KB
AGM Information Classification · 95% confidence The document is titled 'NOTICE OF ANNUAL GENERAL MEETING' and includes detailed information about the upcoming AGM of EMVision Medical Devices Ltd, including the date, location, agenda items, and instructions for voting and proxy appointments. It references the Annual Financial Report, Directors' Report, and Auditor's Report for the year ended 30 June 2019, but does not contain the reports themselves. The document also includes resolutions to be voted on at the AGM, such as adoption of the Remuneration Report and re-election of directors. The length is about 15,000 characters, but the content is clearly a notice and explanatory statement for the AGM, not the actual annual report or financial statements. Therefore, this document is best classified as AGM Information (AGM-R).
2019-10-24 English
Pause In Trading 1 page 111.1KB
Regulatory Filings Classification · 95% confidence The document is a brief market release announcing a temporary pause in trading of the company's securities. It is very short (347 characters) and does not contain any financial data, report content, or detailed information. It is an announcement related to trading status rather than a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-10-08 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.